MedPath

Oxacillin

Oxacillin for Injection, USP(For Intravenous or Intramuscular Injection)

Approved
Approval ID

c4c9bc2d-fe19-4aca-8042-42394d3a3510

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 10, 2018

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 796852890

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

oxacillin sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-162
Application NumberANDA091246
Product Classification
M
Marketing Category
C73584
G
Generic Name
oxacillin sodium
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateSeptember 10, 2018
FDA Product Classification

INGREDIENTS (2)

oxacillin sodiumActive
Quantity: 2 g in 1 1
Code: G0V6C994Q5
Classification: ACTIM
sodium phosphate, dibasicInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxacillin - FDA Drug Approval Details